A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation - Carr, R; Modi, N; Doré, C J; El-Rifai, R; Lindo, D (Pediatrics, 1999)
(4 Pt 1):